BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18375652)

  • 1. Implementation of NIH inclusion guidelines: survey of NIH study section members.
    Taylor HA
    Clin Trials; 2008; 5(2):140-6. PubMed ID: 18375652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of the NIH Sex-Inclusion Policy: Attitudes and Opinions of Study Section Members.
    Woitowich NC; Woodruff TK
    J Womens Health (Larchmt); 2019 Jan; 28(1):9-16. PubMed ID: 30539677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inclusion of women, minorities, and children in clinical trials: opinions of research ethics board administrators.
    Taylor HA
    J Empir Res Hum Res Ethics; 2009 Jun; 4(2):65-73. PubMed ID: 19480593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hispanic research: implications of the National Institutes of Health guidelines on inclusion of women and minorities in clinical research.
    Caban CE
    J Natl Cancer Inst Monogr; 1995; (18):165-9. PubMed ID: 8562217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How the new NIH Guidelines on Inclusion of Women and Minorities apply: efficacy trials, effectiveness trials, and validity.
    Hohmann AA; Parron DL
    J Consult Clin Psychol; 1996 Oct; 64(5):851-5. PubMed ID: 8916610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigators' assessment of NIH mandated inclusion of women and minorities in research.
    Corbie-Smith GM; Durant RW; St George DM
    Contemp Clin Trials; 2006 Dec; 27(6):571-9. PubMed ID: 16843069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The More Things Change, the More They Stay the Same: A Study to Evaluate Compliance With Inclusion and Assessment of Women and Minorities in Randomized Controlled Trials.
    Geller SE; Koch AR; Roesch P; Filut A; Hallgren E; Carnes M
    Acad Med; 2018 Apr; 93(4):630-635. PubMed ID: 29053489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comments on NIH clinical trials valid analysis requirement.
    Meinert CL
    Control Clin Trials; 1995 Oct; 16(5):304-6. PubMed ID: 8582148
    [No Abstract]   [Full Text] [Related]  

  • 9. Underreporting of Gender and Race/Ethnicity Differences in NIH-Funded Dementia Caregiver Support Interventions.
    Gilmore-Bykovskyi A; Johnson R; Walljasper L; Block L; Werner N
    Am J Alzheimers Dis Other Demen; 2018 May; 33(3):145-152. PubMed ID: 29281895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Women subjects in NIH-funded clinical research literature: lack of progress in both representation and analysis by sex.
    Vidaver RM; Lafleur B; Tong C; Bradshaw R; Marts SA
    J Womens Health Gend Based Med; 2000 Jun; 9(5):495-504. PubMed ID: 10883941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory impediments jeopardizing the conduct of clinical trials in Europe funded by the National Institutes of Health.
    Neaton JD; Babiker A; Bohnhorst M; Darbyshire J; Denning E; Frishman A; Grarup J; Larson G; Lundgren J
    Clin Trials; 2010 Dec; 7(6):705-18. PubMed ID: 20729252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inclusion, analysis, and reporting of sex and race/ethnicity in clinical trials: have we made progress?
    Geller SE; Koch A; Pellettieri B; Carnes M
    J Womens Health (Larchmt); 2011 Mar; 20(3):315-20. PubMed ID: 21351877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The new NIH and FDA medical research policies: targeting gender, promoting justice.
    Baird KL
    J Health Polit Policy Law; 1999 Jun; 24(3):531-65. PubMed ID: 10386326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inclusion of racial and ethnic minorities in genetic research: advance the spirit by changing the rules?
    Knerr S; Wayman D; Bonham VL
    J Law Med Ethics; 2011; 39(3):502-12. PubMed ID: 21871045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to federal guidelines for reporting of sex and race/ethnicity in clinical trials.
    Geller SE; Adams MG; Carnes M
    J Womens Health (Larchmt); 2006 Dec; 15(10):1123-31. PubMed ID: 17199453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The NIH inclusion guidelines: challenges for the future.
    Rothenberg KH; Hayunga EG; Rudick JE; Pinn VW
    IRB; 1996; 18(3):1-4, 12. PubMed ID: 11654407
    [No Abstract]   [Full Text] [Related]  

  • 18. Inclusion of women and minorities in clinical trials and the NIH Revitalization Act of 1993--the perspective of NIH clinical trialists.
    Freedman LS; Simon R; Foulkes MA; Friedman L; Geller NL; Gordon DJ; Mowery R
    Control Clin Trials; 1995 Oct; 16(5):277-85; discussion 286-9, 293-309. PubMed ID: 8582146
    [No Abstract]   [Full Text] [Related]  

  • 19. The inclusion of women and minorities in smoking cessation clinical trials: a systematic review.
    Dickerson DL; Leeman RF; Mazure CM; O'Malley SS
    Am J Addict; 2009; 18(1):21-8. PubMed ID: 19219662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exception from informed consent: viewpoint of institutional review boards--balancing risks to subjects, community consultation, and future directions.
    Ernst AA; Fish S
    Acad Emerg Med; 2005 Nov; 12(11):1050-5. PubMed ID: 16264073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.